$ESLA

$0.82 -$0.11 (11.86%) Close

$ESLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 43.5M shares outstanding

Who owns ESLA?

By type of holder

Institutions 11.0% Insiders 20.7% Everyone else 68.3%

Concentration Top 10 holders own 31.6%

Liu Cheng 10.9% · Xu Jiandong 9.7%

Institutional ownership

11.0%

-0.9 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

−384.6K

by institutions in Q2 2026

New / sold out

2 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Vanguard Capital Management LLC +34.4K
Northern Trust Corp +15.2K

Biggest sellers in Q2 2026

Wells Fargo & Company/mn SOLD OUT −264.4K
Armistice Capital, LLC −123.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Estrella Immunopharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+11942.9%

+997.40% a year

Each share's claim on the business

−99.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.22M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years15% Under 1 year85%

Quarterly turnover

5.0%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting ESLA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC Armistice Capital, LLC	4.0M	9.14%	−123.8K (−3.0%)	Q1 '26	0.1%
Shares held by quarter Peak holding4.1M (Q1'26) Change over 8 quarters+4.0M Share of the company9.140% Armistice Capital, LLC's full portfolio →
VC Vanguard Capital Management LLC	416.9K	0.96%	+34.4K (+9.0%)	2024	0.0%
Shares held by quarter Peak holding416.9K (Q2'26) Change over 8 quarters+416.9K Share of the company0.960% Vanguard Capital Management LLC's full portfolio →

Armistice Capital, LLC

4.0M

% of company

9.14%

Change vs last qtr

−123.8K (−3.0%)

Held since

Q1 '26

Vanguard Capital Management LLC

416.9K

% of company

0.96%

Change vs last qtr

+34.4K (+9.0%)

Held since

2024

16 more super investors behind a free account

See every manager holding Estrella Immunopharma Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ESLA on Form N-PORT; together they hold 1.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$279K	268.6K	0.62%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$154K	148.2K	0.34%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$279K

% of company

0.62%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$154K

% of company

0.34%

% of the fund

0.00%

As of

June 30, 2026

6 more funds behind a free account

See every fund holding Estrella Immunopharma Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LC Liu Cheng Insider	4.8M	10.94%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company10.940% Liu Cheng's insider activity →
XJ Xu Jiandong Insider	4.2M	9.73%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company9.730% Xu Jiandong's insider activity →

Liu Cheng

Insider

4.8M

% of company

10.94%

Change vs last qtr

—

Held since

—

Xu Jiandong

Insider

4.2M

% of company

9.73%

Change vs last qtr

—

Held since

—

Comments